Financial Ratios

HEALTHFORE TECHNOLOGIES LTD.

NSE : NABSE : 533525ISIN CODE : INE402L01017Industry : IT - SoftwareHouse : Private
BSE6.640 (0 %)
PREV CLOSE ( ) 6.64
OPEN PRICE ( ) 6.64
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1
TODAY'S LOW / HIGH ( )6.64 6.64
52 WK LOW / HIGH ( ) 6.646.64
NSE
This Company is not listed in NSE
Select year
ParticularsMar2017Mar2016Mar2015Mar2014Mar2013
Operational & Financial Ratios
   Earnings Per Share (Rs)-109.44-90.53-73.32-80.66-83.51
   CEPS(Rs)-102.08-83.63-63.74-65.11-67.95
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-683.69-571.20-483.34-406.14-312.59
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-20.72-21.08-10.38-38.03-93.67
   EBIT Margin(%)-47.57-26.168.97-68.40-88.41
   Pre Tax Margin(%)-514.07-400.84-300.58-240.63-319.89
   PAT Margin (%)-514.07-400.84-300.58-240.63-319.89
   Cash Profit Margin (%)-479.51-370.29-261.29-194.26-260.28
Performance Ratios
   ROA(%)-89.11-60.10-51.46-79.96-44.05
   ROE(%)0.000.000.000.000.00
   ROCE(%)-16.76-5.342.09-31.68-14.00
   Asset Turnover(x)0.170.150.170.330.14
   Sales/Fixed Asset(x)0.230.240.300.480.36
   Working Capital/Sales(x)-0.04-0.06-0.12-0.15-0.07
Efficiency Ratios
   Fixed Capital/Sales(x)4.414.193.382.102.82
   Receivable days249.00248.08209.82114.27160.23
   Inventory Days0.000.000.000.000.00
   Payable days145.80276.62
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-0.25-0.35-0.51-0.39-0.18
   Price/Book(x)-0.04-0.05-0.07-0.06-0.04
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)35.1230.0026.6414.7815.28
   EV/Core EBITDA(x)-269.82684.8755.20-67.12-53.02
   EV/EBIT(x)-73.82-114.69297.06-21.61-17.28
   EV/CE(x)5.995.613.604.744.10
   M Cap / Sales1.181.291.330.750.47
Growth Ratio
   Net Sales Growth(%)-5.74-7.41-27.2328.39-65.72
   Core EBITDA Growth(%)-380.04-91.59259.431.8429.58
   EBIT Growth(%)-71.41-370.13109.540.6726.81
   PAT Growth(%)-20.89-23.489.103.426.92
   EPS Growth(%)-20.89-23.489.103.426.92
Financial Stability Ratios
   Total Debt/Equity(x)-1.06-1.14-1.29-1.17-1.24
   Current Ratio(x)0.060.090.340.130.08
   Quick Ratio(x)0.060.090.340.130.08
   Interest Cover(x)-0.10-0.070.03-0.40-0.38
   Total Debt/Mcap(x)28.7422.4219.2418.8732.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.